Skip to content
TrackPodcasts
newsApr 25, 20261:10

J&J Drops 4 Drugs on TrumpRx, Boosting Access

About this episode

Johnson & Johnson to Launch Four Prescription Drugs on TrumpRx, Aiming for Affordable Access

Support the show:
Get a discount at https://solipillow.com/discount/dnn.

Advertise on DNN:
[email protected]

This is an automated, high-level news summary based on public reporting.
Report issues to [email protected].

View sources & latest updates:
https://sources.thednn.ai/f553d481738266d4

Get every episode summarized

Each time US News Today | 2 Min News | The Daily News Now! publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.

Email me new episodes

Free for 3 shows. No card needed.

Transcript ready

19 searchable segments. Every word is indexed and playable.

J&J Drops 4 Drugs on TrumpRx, Boosting Access

US News Today | 2 Min News | The Daily News Now!

0:00
1:10

Full transcript

US News Today | 2 Min News | The Daily News Now!J&J Drops 4 Drugs on TrumpRx, Boosting Access. Machine-transcribed; use the interactive transcript above to jump the player to any line.

It's April 24. From breaking headlines to national stories, this is US News Today, powered by AI. Johnson and Johnson is set to drop four of its prescription drugs on the Trump administration's Trump RX website this Friday. It's a big move to make meds more accessible, straight from CBS News reports. This kicks off marketing right there on the platform, aimed at everyday folks hunting for deals. Back in January, J&J cut a voluntary deal with the Trump team. They agreed to slash prices for Americans and boost access through Medicaid programs. In return, they get a pass on those hefty administration tariffs hitting imports. For patients, this could mean real relief at the pharmacy counter, especially under Medicaid, where costs often stack up. It's part of a push to level the playing field on drug pricing without the usual red tape battles. Details on exactly which four drugs are still under wraps. Rotors couldn't confirm them yet. J&J hasn't hit back on comma requests either, so we're watching for that reveal.

As this rolls out, keep an eye on Trump RX. It might just reshape how we snag affordable scripts in this wild healthcare game.

More episodes

More from US News Today | 2 Min News | The Daily News Now!

View all episodes →